Shubhra Rastogi

1PUBLICATIONS
5CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 20, 2025
Preclinical Activity of the Type II RAF Inhibitor Tovorafenib in Tumor Models Harboring Either a BRAF Fusion or an NF1 Loss-of-Function Mutation.

Shubhra Rastogi, Samantha Perino, Madhu Lal-Nag

Pageof 1

Frequent Collaborators

1 joint publications

Samantha Perino

1 joint publications

Madhu Lal-Nag

1 joint publications

Yujin Wang

1 joint publications

Samuel C Blackman